Skip to main content
PHAGE: Therapy, Applications, and Research logoLink to PHAGE: Therapy, Applications, and Research
. 2024 Jun 21;5(2):107–116. doi: 10.1089/phage.2023.0020

Two Novel Bacteriophage Species Against Hybrid Intestinal Pathogenic Escherichia coli/Extraintestinal Pathogenic Escherichia coli Strains

Napakhwan Imklin 1, Pattaraporn Sriprasong 1, Narut Thanantong 2, Porntippa Lekcharoensuk 3,4,, Rujikan Nasanit 1,
PMCID: PMC11304831  PMID: 39119207

Abstract

Background:

Colibacillosis caused by Escherichia coli is one of the main problems in the swine industry. In addition, the emergence of antimicrobial resistance and the combination of virulence genes among pathotypes have led to the emergence of more virulent pathogenic E. coli strains. Phage therapy has become a promising approach to address these issues.

Materials and Methods:

Virulence genes for intestinal pathogenic E. coli (IPEC) and extraintestinal pathogenic E. coli (ExPEC) were investigated in pathogenic E. coli isolated from pigs. In addition, two potential phages, vB_EcoM-RPN187 and vB_EcoM-RPN226, isolated in our previous study, were further characterized in this study.

Results:

Both phages were lytic and were highly effective at 20–37°C. Interestingly, they infected the hybrid IPEC/ExPEC strains. vB_EcoM-RPN187 and vB_EcoM-RPN226 possess 167 kbp of linear double-stranded DNA without virulence or antibiotic resistance genes and may be classified as new phage species in the genera Mosigvirus and Tequatrovirus, respectively.

Conclusion:

Both phages could be promising candidates for phage therapy against pathogenic E. coli.

Keywords: bacteriophage, Escherichia coli, ExPEC, IPEC, pig

Introduction

In the swine industry, production losses have a negative financial impact on both producers and consumers when expenses and supply–demand dynamics are considered. Colibacillosis caused by Escherichia coli is one of the main causes of production loss. This infectious disease is recognized as one of the most serious causes of illness and death in piglets. There are two main categories of E. coli known as intestinal pathogenic E. coli (IPEC) and extraintestinal pathogenic E. coli (ExPEC).

The former category, also called diarrheagenic E. coli (DEC), consists of six well-studied pathotypes, which are enteropathogenic E. coli (EPEC), Shiga toxin-producing E. coli (STEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent E. coli (DAEC). In contrast, ExPEC can be divided into uropathogenic E. coli (UPEC), neonatal meningitis-associated E. coli (NMEC), septicemic E. coli (SePEC), avian pathogenic E. coli (APEC), and endometrial pathogenic E. coli (EnPEC).

These pathotypes are identified based on the presence of virulence genes and their pathotypic traits.1,2 The combination of virulence genes among pathotypes, and between IPEC and ExPEC, has led to the emergence of more virulent pathogenic E. coli strains. STEC O2:H6 harbored UPEC virulence-associated genes, leading to diarrhea and urinary tract infection. It was later called a STEC/UPEC hybrid pathogen, which caused both intestinal and extraintestinal diseases.3 It has been suggested that hybrid E. coli pathogens should be considered as a public health concern.4

Generally, antibiotics are the first option for treating infected pigs. Nevertheless, this treatment is not always successful because various pathogenic strains select for antibiotic resistance. A high number of ETEC (59%) and ETEC/STEC (53%) isolates were resistant to at least six drug categories. In addition, 14 of 15 hybrid ETEC/STEC isolates resisted colistin, a restricted antibiotic, raising serious concerns.5

Moreover, hybrid UPEC/EAEC isolates from ambulatory patients showed multidrug resistance profiles. Further clinical research was recommended because of the increased probability of developing pyelonephritis.6 Although different classes of antibiotics are available to treat bacterial infectious diseases, the emergence of multidrug-resistant bacteria has become a critical issue that needs to be considered and has led to more difficult treatment.

Phages are known as potential bioagents for bacterial control in a variety of applications such as phage therapy, disinfectants, and food safety.7 Strictly lytic phages have generally been preferred for therapeutic purposes as they only possess a lytic life cycle that destroys the infected bacterial cells, whereas temperate phages have been circumvented due to their capacity to facilitate transduction, which mediates gene transfer between bacteria and may increase bacterial virulence. Temperate phages may be an option in some circumstances.8 Despite its economic importance, phage-host specificity, and increasing interest in phage therapy, there have only been a few reports of phages associated with swine pathogens in Thailand.9–11

In our previous work, vB_EcoM-RPN187 and vB_EcoM-RPN226 phages were isolated using multidrug-resistant E. coli M187 and M226, isolated from diarrheal pig intestines, respectively, as hosts.12 Both phages were combined with other potential phages to form a phage cocktail, which successfully reduced the number of fecal E. coli in artificially E. coli-infected nursery pigs.12

In this report, the virulence factors associated with IPEC and ExPEC in both E. coli host strains and other susceptible E. coli strains are presented. Furthermore, other characteristics and the complete genomes of both phages are reported to reveal their capability and safety for use in phage therapy against pathogenic E. coli. The taxonomy of both phages is also classified based on genome annotation.

Materials and Methods

Bacteria and bacteriophages used in this study

Bacteriophages vB_EcoM-RPN187 and vB_EcoM-RPN226 were previously isolated from drained water samples collected from pork stalls.12 In this study, 29 other bacterial strains were used to determine the phage host range (Supplementary Table S1). All strains were cultured in tryptic soy broth (TSB) for 16–18 h before each experiment and phage enumeration.

Virulence factor investigation

The investigation was conducted using the colony polymerase chain reaction (PCR) technique with 23 primers. These primers are specific to E. coli uspA, faeG, fanA, fasA, fedA, fimF41a, elt, sta, stb,13 stx1, stx2, eaeA, hlyA,14 stx2e,15 csgA,16 aggR,17 fimH, kpsMTII, ibeA, fyuA, traT,18 cdtI-VB,19 and agn43 genes20 (Supplementary Table S2). A fresh single colony of each E. coli strain (E. coli M158–M245 isolated from diarrheal pigs) was partly picked and suspended in sterilized deionized water.

The colony PCR mixture consisted of 2 μL of the cell suspension, 0.2 pmol of each primer, 12.5 μL of hot-start PCR master mix (Apsalagen, Thailand) and was adjusted to 25 μL using deionized water. The reactions were carried out for 35 cycles as follows: initial denaturation at 94°C for 10 min, denaturation at 94°C for 1 min, annealing at different temperatures (Supplementary Table S2) for 30 s, extension at 72°C for 30 s (60 s for the uspA and fyuA genes), and final extension at 72°C for 10 min. PCR products were visualized by agarose gel electrophoresis.

Host range determination

Phages were further explored for their efficiency against 29 other bacterial strains, including 22 E. coli strains, 1 Klebsiella pneumoniae strain, 5 Salmonella enterica strains, and 1 Staphylococcus aureus strain (Supplementary Table S1). The experiment was performed using the double layer agar (DLA) method. The efficiency of plating (EOP) value was determined to indicate phage capacity for lysing susceptible bacteria.21

EOP at different temperatures

The EOP was also investigated at a range of temperatures (10–45°C) following Seeley and Primrose22 with some modifications. The test was conducted using the DLA method and incubated at 10°C, 15°C, 20°C, 25°C, 30°C, 37°C, 42°C, and 45°C for 18–48 h. The EOP value can be calculated by dividing the phage titer at the tested temperature by the highest phage titer at an optimal temperature. The phage efficiency was indicated as previously described.21

Thermal and pH stabilities

To determine temperature stability, phage suspensions in SM buffer were incubated at 4°C, 28°C, 37°C, 50°C, 60°C, and 70°C for 1 h. For pH stability, the phage suspension was 100-fold diluted in TSB at different pH levels (2–11) and incubated at 37°C for 1 h. After incubation, the samples were immediately subjected to DLA. The phage titer was calculated to determine phage stability compared with the initial phage titer.

One-step growth curve

Phage one-step growth was performed according to the method described by Imklin and Nasanit.21 In brief, phage suspension was mixed with host bacteria in 30 mL of TSB at a multiplicity of infection of 0.001 and incubated for 5 min. Centrifugation was performed to discard free phages. Cell pellets were resuspended in pre-warmed TSB at the same volume. The samples were taken every 5 min for phage enumeration.

The burst size was calculated by dividing the average phage titer at each time point by the average initial phage titer, and growth curves were constructed. It should be noted that the starting point of the graph in this study corresponds to a particular time when the cell pellet was resuspended. In addition, the latent period started from the beginning of the infection, when phages and bacteria were encountered, to the beginning of the burst period.

Complete genome analysis

Phage genomic DNA was extracted using the phenol-chloroform method.21 Illumina sequencing by synthesis technology (Macrogen, Korea) was utilized to perform short-read sequencing of 101 bases using a Nextera XT DNA Library Preparation Kit and a TruSeq Nano DNA Kit for vB_EcoM-RPN187 and vB_EcoM-RPN226, respectively.

The raw reads were trimmed and filtered using Trimmomatic (v0.36)23 to obtain good-quality bases (∼98%) at a phred quality score of 30 for both phage genomes. FastQC (v0.11.5) was used to check the overall quality of the data. The obtained reads were subjected to de novo assembly using SPAdes (v3.13.0)24 to create a single contig representing the phage genome. Filtering, trimming, and assembly were performed by Macrogen (the Republic of Korea).

The nucleotide sequences of both ends of the received contig were verified by the PCR technique before genome annotation. Each PCR product of contig ends was amplified using the designed primers RPN187-F 5′-GGCACAAAGAAGTCCTCGAA-3′ and RPN187-R 5′-GCCAATGATGCCACCAACAAC-3′ for vB_EcoM-RPN187, and RPN226-F 5′-GGAGCGAATAACGGAACAACC-3′ and RPN226-R 5′-CCTCTACGAGTTTCTGTGGCA-3′ for vB_EcoM-RPN226. Open reading frames (ORF) were predicted using Glimmer 325 through Geneious Prime (v2023.2.1) and GeneMarkS (v3.26)26 with default settings.

Amino acid sequences were translated and extracted from Geneious Prime in the FASTA format. Protein functions were predicted by comparing amino acid sequences using BLASTp against the nonredundant protein sequences (nr) database with an E-value cutoff of 1E-10. NCBI-conserved domains, HHpred, and Uniprot were additionally used in conjunction with the BLASTp results to identify putative protein functions. Only those proteins that met at least 90% identity from the BLASTp results and contained conserved domains were assigned as functional proteins, whereas other proteins were hypothetical proteins.

Aragorn (v1.2.41) was used to find tRNA gene with the default setting.27 The genome sequence was annotated and submitted to the GenBank database through Geneious Prime. Amino acid sequences of the terminase large subunit (TerL) and major capsid protein (MCP) were aligned before constructing phylogenetic trees using MEGA 7 with 1000 bootstrap replicates under the maximum likelihood method with the Jones–Taylor–Thornton model.28 Nearest-Neighbor-Interchange and default NJ/BioNJ methods were combined for tree topology analyses.

To determine the similarity between both vB_EcoM-RPN187 and vB_EcoM-RPN226 phages and their relatives, whole genome sequences were subjected to BLASTn and PAirwise Sequence Comparison (PASC) analysis with default settings.29 Consequently, each closest relative according to the PASC result was genetically compared with each phage DNA sequence using a linear comparison application, Easyfig (v2.2.2).30 The complete genome sequences of Escherichia phages vB_EcoM-RPN187 and vB_EcoM-RPN226 are available from GenBank under the accession numbers OL770074 and OL770073, respectively.

Raw reads of the vB_EcoM-RPN187 and vB_EcoM-RPN226 genomes were submitted to the sequence read archive (SRA) repository following this information: BioProject: PRJNA1055028 and PRJNA1055045, BioSample: SAMN38976064 and SAMN38976473, SRA accession: SRR27315206 and SRR27297327, respectively.

Statistical analysis

The statistical significance of the data in the thermal and pH stability tests was determined by a paired-samples t-test using IBM SPSS Statistics version 23. A value of p < 0.05 was considered to be statistically significant.

Results

Virulence genes in E. coli strains

Of the 23 tested genes, 3–6 virulence genes were detected in the tested E. coli. These included E. coli uspA, stb, stx2, csgA, fimH, kpsMTII, fyuA, traT, and agn43 genes (Supplementary Table S1). Two types of fimbriae-associated genes were found in E. coli M170, but no toxin or other tested virulence genes were identified. In contrast, at least 4 virulence-associated genes were detected in 13 other E. coli strains. These results indicated that most E. coli strains possessed both IPEC and ExPEC virulence genes.

Host range determination

The host range test (Supplementary Table S2) revealed that vB_EcoM-RPN187 was specific to four E. coli strains. vB_EcoM-RPN226 effectively infected nine E. coli strains. Several susceptible E. coli strains carried a combination of both IPEC and ExPEC virulence genes. Notably, the phages could infect pathogenic E. coli, causing diarrhea in pigs and mastitis and metritis in cows.

EOP at different temperatures

The results showed that vB_EcoM-RPN187 and vB_EcoM-RPN226 formed clear plaques at all tested temperatures (Supplementary Fig. S1). vB_EcoM-RPN187 was highly capable of producing plaques against its host at 20–37°C, whereas medium effectiveness was observed at 15°C. However, the phage had low EOP at 10°C, 42°C, and 45°C. The optimal temperature was in the range of 20–37°C. vB_EcoM-RPN226 was highly capable of forming plaques against its host at 30°C, whereas it was moderately effective at 25°C and 37°C. This phage had poor plating efficiency at 10°C, 15°C, 20°C, 42°C, and 45°C.

Thermal and pH stabilities

Both phages survived at a range of temperatures (10–45°C) for 1 h. However, a significant reduction of ∼1–2 log PFU/mL was observed at 60°C and 70°C (supplementary Fig. S2). In addition, they were stable in the pH range 3–10 (Supplementary Fig. S3). A decrease in vB_EcoM-RPN187 titer was observed below pH 4 and above pH 10. vB_EcoM-RPN226 was more stable than vB_EcoM-RPN187 at pH 4 and 10. No plaque-forming units were recovered after exposure to pH 2 and 11 for either phage.

One-step growth curve

The latent and burst periods were ∼20 and 40 min, respectively, for vB_EcoM-RPN187. They were ∼25 and 55 min, respectively, for vB_EcoM-RPN226. The burst sizes of these phages were 19 ± 2 PFU/infected cell (Supplementary Fig. S4).

Complete genome analysis

The genome of vB_EcoM-RPN187 is a linear double-stranded DNA with 167,158 bp and 37.8% GC content. It possesses 265 ORFs and 10 tRNA genes. ORFs were categorized into six groups based on their functions (Fig. 1a). Of the total 265 ORFs, 103 ORFs were predicted to encode functional proteins. Importantly, no virulence, antimicrobial resistance, or toxin genes were detected in the phage genome. The BLAST search information is provided in Supplementary Table S3. Phylogenetic trees demonstrated the genetic relationship between vB_EcoM-RPN187 and virus members in the genus Mosigvirus (Fig. 2).

FIG. 1.

FIG. 1.

The annotated genome map of vB_EcoM-RPN187 (a) and vB_EcoM-RPN226 (b). The arrows and numbers indicate the transcriptional direction and the nucleotide positions, respectively. All ORFs are highlighted based on predicted protein functions. ORFs, open reading frames.

FIG. 2.

FIG. 2.

Phylogenetic analysis based on the amino acid sequence alignment of terminase large subunit (a) and major capsid protein (b) between vB_EcoM-RPN187 (black circle) and its closest relative, S143_2 (open circle) and vB_EcoM-RPN226 (black square) and its closest relative, vB_EcoM_SYGD1 (open square), and other phages. Sequences were gathered from the GenBank database. The phylogenetic trees were constructed by MEGA7 using the maximum likelihood method with 1000 bootstrap replications.

The BLASTn results revealed the similarity between vB_EcoM-RPN187 and the most familiar Escherichia phage S143_2 (MZ189261), with 98.2% identity and 96.0% query cover. The PASC results indicated that ∼94% of the entire nucleotide sequence of vB_EcoM-RPN187 vastly matched that of Escherichia phage S143_2 (Table 1). Genome comparison using the BLASTn algorithm illustrated the reciprocal evolutionary relationship between vB_EcoM-RPN187 and S143_2, with nucleotide similarity ranging from 69% to 100% (Fig. 3a).

Table 1.

The Nucleotide Alignment of Whole Genome Sequences of vB_EcoM-RPN187 and Its Closest Relatives Using Pairwise Sequence Comparison

The overall nucleotide sequence identity (%) Accession number Bacteriophage Genome size (kb) % GC content No. of protein encoding gene No. of tRNA
OL770074 Escherichia phage vB_EcoM-RPN187 167.16 37.8 275 10
94.07 MZ189261 Escherichia phage S143_2 168.77 37.7 270 10
93.48 MN850579 Escherichia phage mogra 168.72 37.7 266 2
93.01 NC_029091 Escherichia phage APCEc01 168.77 37.7 274 2
92.83 MK047718 Escherichia phage p000y 169.87 37.7 276 10
92.81 NC_024124 Escherichia phage vB_EcoM_JS09 169.15 37.6 273 2
92.51 NC_041863 Escherichia coli O157 typing phage 3 168.73 37.6 272 2
92.34 KT184310 Enterobacteria phage ATK48 169.73 37.6 218 2
92.26 NC_055708 Enterobacteria phage ATK47 170.02 37.6 215 2
92.26 NC_054940 Shigella phage JK45 170.74 37.6 275 2
91.98 NC_055781 Escherichia phage p000v 167.80 37.6 264 1

FIG. 3.

FIG. 3.

The linear comparison of full-length genomes between vB_EcoM-RPN187 and Escherichia phage S143_2 (MZ189261) (a) and between vB_EcoM-RPN226 and Escherichia phage vB_EcoM_SYGD1 (MW883059) (b). The dark-light gray gradients present nucleotide similarity.

The genome of vB_EcoM-RPN226 is a linear double-stranded DNA of 167,390 bp and 35.6% GC content. It consists of 265 ORFs and 8 tRNA genes (Fig. 1b). Among these, 115 ORFs were predicted to encode functional proteins (Supplementary Table S4). Importantly, no virulence, antimicrobial resistance, or toxin genes were detected in the phage genome. The phylogenetic trees of TerL (Fig. 2a) and MCP (Fig. 2b) amino acid sequences revealed the closest genetic relationship between vB_EcoM-RPN226 and Escherichia phages in the genus Tequatrovirus.

According to the BLASTn results of the whole genome sequence, vB_EcoM-RPN226 was most closely related to Escherichia phage vB_EcoM_SYGD1 (MW883059), with 96.4% identity and 93.0% query coverage. Furthermore, the PASC result proved that the whole nucleotide sequence of vB_EcoM-RPN226 closely matched that of the Escherichia phage vB_EcoM_SYGD1 by about 89.5% (Table 2). With nucleotide similarity ranging from 67% to 100%, genome comparison using the BLASTn algorithm demonstrated the reciprocal evolutionary relationship between vB_EcoM-RPN226 and vB_EcoM_SYGD1 (Fig. 3b).

Table 2.

The Nucleotide Comparison of Complete Genome Sequences of the vB_EcoM-RPN226 Phage and Its Closest Relatives Conducted by Pairwise Sequence Comparison

The overall nucleotide sequence identity (%) Accession number Bacteriophage Genome size (kb) % GC content No. of protein encoding gene No. of tRNA
OL770073 Escherichia phage vB_EcoM-RPN226 167.39 35.6 265 8
89.53 MW883059 Escherichia phage vB_EcoM_SYGD1 171.26 35.3 271 8
87.75 NC_054904 Enterobacteria phage vB_EcoM_IME340 165.55 35.5 260 10
87.60 MT682709 Escherichia phage vB_EcoM_SP1 165.42 35.6 269 10
87.33 NC_054937 Salmonella phage pSe_SNUABM_01 172.36 35.4 276 6
87.30 MK327928 Escherichia phage vB_EcoM_G2133 168.96 35.3 273 8
87.26 NC_054925 Escherichia phage vB_EcoM_NBG2 166.08 35.4 261 10
87.25 MW822007 Escherichia phage BF15 167.8 35.4 267 8
87.01 KR269718 Escherichia phage HY03 170.77 35.3 269 7
86.92 NC_054930 Escherichia phage PP01 167.81 35.5 280 8
86.70 NC_054916 Escherichia phage vB_EcoM-G28 170.12 35.3 267 8

Discussion

Our previous study revealed that all E. coli strains resisted 2–6 antibiotics.12 In addition, the fact that E. coli strains were isolated from lung specimens and intestines of diarrheal pigs suggests that they may have been involved in swine illnesses. In this study, the IPEC and ExPEC virulence genes were detected in the tested E. coli strains. For example, the stb gene encodes heat-stable enterotoxin b, which responds promptly to an infected host and causes moderate porcine diarrhea.31 Another toxin gene found in some E. coli isolates was the stx2 gene, which encodes Shiga toxin 2 (Stx2).

This toxin is more cytotoxic than Stx1, indicating STEC pathogenicity, which causes hemorrhagic colitis.32 The product of the csgA gene is curli fimbriae, a type of adhesin that can be found in E. coli from the ExPEC category, especially UPEC, and is associated with biofilm formation and enhanced pathogenicity.33 However, STEC, an IPEC pathotype, has been shown to carry this gene.34 The traT gene encodes a complement resistance protein called protectine. ExPEC isolates that produce this protein are serum-resistant, promoting bacterial virulence as they can survive in the bloodstream and cause bacteremia.35,36

It was suggested that those who possessed virulence genes of at least two DEC pathotypes should be referred to hetero-pathogenic strains. For hybrid pathogens, it was adopted for those that carried both DEC and ExPEC virulence genes or for DEC strains isolated from extraintestinal systems.37 Notably, new threats to public health, both humans and animals, could arise from the emergence of drug-resistant E. coli hybrid strains. Interestingly, regarding the host range results, the phages vB_EcoM-RPN187 and vB_EcoM-RPN226 could effectively infect these pathogenic bacteria with at least three strains each.

vB_EcoM-RPN187 and vB_EcoM-RPN226 demonstrated outstanding ability to kill their hosts at temperatures between 20°C and 37°C. Therefore, they could be classified as members of mid-temperature phages.22 According to the stability results, it is expected that both phages would effectively traverse the gastrointestinal tract of piglets and maintain their efficacy under in vivo conditions through oral administration. Notably, the gastric and intestinal pH of piglets varied in a range of 3.0–4.1 and 5.1–6.5, respectively.38

In addition, piglet body temperatures typically fall between 36.8°C and 39.2°C.39 These inherent characteristics of both phages hold significant value, as they demonstrate a remarkable capacity to combat pathogens under diverse piglet physiological conditions. Furthermore, both phages exhibited rapid host cell lysis, as observed in the one-step growth experiment, which further enhances their potential as effective bactericidal agents.

Several genes in the vB_EcoM-RPN187 and vB_EcoM-RPN226 genomes are associated with phage–host interactions, for example, the discriminator of mRNA degradation protein, which is required to protect phage mRNAs from host RNase LS40; RNA ligase A, which is responsible for repairing damaged phage tRNA caused by a host defense system41; and polynucleotide kinase and RNA ligase 2, both of which involve repairing nicked tRNA caused by a host response mechanism.42

These genes demonstrate that the phages possess the ability to circumvent the defense mechanisms of their hosts. Moreover, the absence of virulence, antimicrobial resistance, and toxin genes was observed in both the phage genomes. These results suggested the suitability of phages for therapeutic purposes.

It was discovered that vB_EcoM-RPN187 and vB_EcoM-RPN226 were genetically closely related to phages in the genera Mosigvirus and Tequatrovirus, respectively. vB_EcoM-RPN187 has a prolate icosahedral head, a long tail with a contractile sheath, and long-tail fibers (supplementary Fig. S5a). These structural characteristics resemble those of Escherichia phage APCEc01, which is classified as a viral species within the genus Mosigvirus.43

Genes encoding the long-tail fiber protein and long-tail fiber proximal subunit were also detected in the vB_EcoM-RPN187 genome. However, the APCEc01 phage has a larger genome than the vB_EcoM-RPN187 phage. This suggests that vB_EcoM-RPN187 may be considered a novel member of the Mosigvirus genus. When compared with its closest genetically related phage, Escherichia phage S143_2, a high percentage of whole genome similarity (94%) was observed.

Nevertheless, notable differences existed between the two phages. The whole genome comparison (Fig. 3a) illustrated a low percentage (light gray) similarity in the last detected structural protein, the tail protein, between vB_EcoM-RPN187 (ULA51974) and S143_2 (QWV60330). The BLASTp summary displayed the alignment of these amino acid sequences with 100% query coverage and 59.8% identity, indicating a distinct tail morphology. However, there is currently no publicly available report regarding the characteristics of Escherichia phage S143_2.

It was found that the vB_EcoM-RPN226 genomic DNA sequence was most closely related to that of vB_EcoM_SYGD1.44 The vB_EcoM_SYGD1 genome comprises 171,255 bp with 35.3% GC content and a total of 271 ORFs and 8 tRNAs. Notably, vB_EcoM-RPN226 has a shorter nucleotide sequence and fewer ORFs than vB_EcoM_SYGD1, whereas the GC content percentage does not significantly differ. Linear DNA comparison, as shown in Figure 3b, highlights the genetic distinctions between the two phage genomes.

However, notable differences were observed in the stability characteristics of the two phages. Regarding its physical traits, vB_EcoM-RPN226 has a prolate icosahedral head, a long contractile tail, and long-tail fibers with baseplates (Supplementary Fig. S5b), similar to that of vB_EcoM_SYGD1. Although both phages exhibited substantial similarities in both genetic and morphological information, the presence of characteristic differences suggests that vB_EcoM-RPN226 may be considered a new member of the genus Tequatrovirus.

To classify phage taxonomy, phages whose entire genomes share >95% nucleotide identity are assigned as to the same species. Furthermore, the threshold for assigning phages to different genera is set at 70% nucleotide similarity of the complete genome.45 According to the guidelines, phylogenetic trees, BLASTn, and PASC results, vB_EcoM-RPN187 and vB_EcoM-RPN226 may potentially represent new phage species in the genus Mosigvirus and Tequatrovirus, respectively.

Conclusion

In summary, vB_EcoM-RPN187 and vB_EcoM-RPN226 presented their capability of infecting multidrug-resistant hybrid pathogenic E. coli strains at a wide range of temperatures. These phages have shown resilience within the piglet body temperature range and varying pH levels of the digestive tract, thereby increasing their potential to reach bacterial targets in the gut. Furthermore, no undesirable genes were detected in their genomes. These characteristics establish vB_EcoM-RPN187 and vB_EcoM-RPN226 as novel Escherichia phages with promising potential as bactericidal agents for effectively managing the causative bacteria in swine production.

Supplementary Material

Supplementary Table S1
Supplementary Table S2
Supplementary Table S3
Supplementary Table S4
Supplementary Figure S1
Supplementary Figure S2
Supplementary Figure S3
Supplementary Figure S4
Supplementary Figure S5

Acknowledgments

We thank Assoc. Prof. Somchai Sajapitak, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom (Thailand), for providing us with various E. coli strains used in the phage host range test. We are grateful to Laurence Crouch for literary language assistance.

Authors' Contributions

The study conception, design, and supervision were contributed by R.N. Methodology and investigation were performed by N.I., P.S., and N.T. Formal analysis was performed by N.I. and P.S. Writing—original draft and visualization were done by N.I. Funding acquisition and project administration were contributed by P.L. and R.N. All authors read, commented, and approved the final article.

Author Disclosure Statement

No completing financial interests exist.

Funding Information

This study was supported by the Kasetsart University Research and Development Institute, KURDI (Grant No. FF(KU)17.64).

References

  • 1. Lindstedt BA, Finton MD, Porcellato D, et al. High frequency of hybrid Escherichia coli strains with combined Intestinal Pathogenic Escherichia coli (IPEC) and Extraintestinal Pathogenic Escherichia coli (ExPEC) virulence factors isolated from human faecal samples. BMC Infect Dis 2018;18(1):544; doi: 10.1186/s12879-018-3449-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Patzi-Vargas S, Zaidi MB, Perez-Martinez I, et al. Diarrheagenic Escherichia coli carrying supplementary virulence genes are an important cause of moderate to severe diarrhoeal disease in Mexico. PLoS Negl Trop Dis 2015;9(3):e0003510; doi: 10.1371/journal.pntd.0003510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bielaszewska M, Schiller R, Lammers L, et al. Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6. EMBO Mol Med 2014;6(3):347–357; doi: 10.1002/emmm.201303133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Nyholm O, Halkilahti J, Wiklund G, et al. Comparative genomics and characterization of hybrid shigatoxigenic and enterotoxigenic Escherichia coli (STEC/ETEC) strains. PLoS One 2015;10(8):e0135936; doi: 10.1371/journal.pone.0135936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Garcia-Menino I, Garcia V, Alonso MP, et al. Clones of enterotoxigenic and Shiga toxin-producing Escherichia coli implicated in swine enteric colibacillosis in Spain and rates of antibiotic resistance. Vet Microbiol 2021;252:108924; doi: 10.1016/j.vetmic.2020.108924 [DOI] [PubMed] [Google Scholar]
  • 6. Martinez-Santos VI, Ruiz-Rosas M, Ramirez-Peralta A, et al. Enteroaggregative Escherichia coli is associated with antibiotic resistance and urinary tract infection symptomatology. PeerJ 2021;9:e11726; doi: 10.7717/peerj.11726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Harada LK, Silva EC, Campos WF, et al. Biotechnological applications of bacteriophages: State of the art. Microbiol Res 2018;212–213:38–58; doi: 10.1016/j.micres.2018.04.007 [DOI] [PubMed] [Google Scholar]
  • 8. Nale JY, Spencer J, Hargreaves KR, et al. Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo. Antimicrob Agents Chemother 2016;60(2):968–981; doi: 10.1128/AAC.01774-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Leknoi Y, Mongkolsuk S, Sirikanchana K. Assessment of swine-specific bacteriophages of Bacteroides fragilis in swine farms with different antibiotic practices. J Water Health 2017;15(2):251–261; doi: 10.2166/wh.2016.069 [DOI] [PubMed] [Google Scholar]
  • 10. Songphasuk T, Imklin N, Sriprasong P, et al. Bacteriophage efficacy in controlling swine enteric colibacillosis pathogens: An in vitro study. Vet World 2022;15(12):2822–2829; doi: 10.14202/vetworld.2022.2822-2829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Sriprasong P, Imklin N, Nasanit R. Selection and characterization of bacteriophages specific to Salmonella Choleraesuis in swine. Vet World 2022;15(12):2856–2869; doi: 10.14202/vetworld.2022.2856-2869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Imklin N, Sriprasong P, Phuttapatimok S, et al. In vivo assessment of bacteriophages specific to multidrug resistant Escherichia coli on fecal bacterial counts and microbiome in nursery pigs. Res Vet Sci 2022;151:138–148; doi: 10.1016/j.rvsc.2022.07.012 [DOI] [PubMed] [Google Scholar]
  • 13. Wang W, Zijlstra RT, Ganzle MG. Identification and quantification of virulence factors of enterotoxigenic Escherichia coli by high-resolution melting curve quantitative PCR. BMC Microbiol 2017;17(1):114; doi: 10.1186/s12866-017-1023-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Paton AE, Paton JC. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol 1998;36(2):598–602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Osek J, Gallien P, Truszczynski M, et al. The use of polymerase chain reaction for determination of virulence factors of Escherichia coli strains isolated from pigs in Poland. Comp Immun Microbiol Infect Dis 1999;22:163–174. [DOI] [PubMed] [Google Scholar]
  • 16. Maurer JJ, Brown TP, Steffens WL, et al. The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin tsh among avian Escherichia coli. Avian Dis 1998;42(1):106–118. [PubMed] [Google Scholar]
  • 17. Cerna J, Nataro J, Estrada-Garcia T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol 2003;41(5):2138–2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261–272. [DOI] [PubMed] [Google Scholar]
  • 19. Hinenoya A, Naigita A, Ninomiya K, et al. Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan. Microbiol Immunol 2009;53(4):206–215; doi: 10.1111/j.1348-0421.2009.00116.x [DOI] [PubMed] [Google Scholar]
  • 20. Gonzalez Moreno C, Torres Luque A, Oliszewski R, et al. Characterization of native Escherichia coli populations from bovine vagina of healthy heifers and cows with postpartum uterine disease. PLoS One 2020;15(6):e0228294; doi: 10.1371/journal.pone.0228294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Imklin N, Nasanit R. Characterization of Salmonella bacteriophages and their potential use in dishwashing materials. J Appl Microbiol 2020;129(2):266–277; doi: 10.1111/jam.14617 [DOI] [PubMed] [Google Scholar]
  • 22. Seeley ND, Primrose SB. The effect of temperature on the ecology of aquatic bacteriophages. J Gen Virol 1980;46:87–95. [Google Scholar]
  • 23. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014;30:2114–2120; doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Bankevich A, Nurk S, Antipov D, et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012;19:455–477; doi: 10.1089/cmb.2012.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Delcher AL, Bratke KA, Powers EC, et al. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 2007;23(6):673–679; doi: 10.1093/bioinformatics/btm009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Besemer J, Lomsadze A, Borodovsky M. GeneMarkS—A self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 2001;29:2607–2618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Laslett D, Canback B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res 2004;32(1):11–16; doi: 10.1093/nar/gkh152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016;33(7):1870–1874; doi: 10.1093/molbev/msw054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Bao Y, Chetvernin V, Tatusova T. Improvements to pairwise sequence comparison (PASC): A genome-based web tool for virus classification. Arch Virol 2014;159(12):3293–3304; doi: 10.1007/s00705-014-2197-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Sullivan MJ, Petty NK, Beatson SA. Easyfig: A genome comparison visualizer. Bioinformatics 2011;27(7):1009–1010; doi: 10.1093/bioinformatics/btr039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Dubreuil JD, Isaacson RE, Schifferli DM. Animal enterotoxigenic Escherichia coli. EcoSal Plus 2016;7(1); doi: 10.1128/ecosalplus.ESP-0006-2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Remfry SE, Amachawadi RG, Shi X, et al. Shiga toxin-producing Escherichia coli in feces of finisher pigs: isolation, identification, and public health implications of major and minor serogroupsdagger. J Food Prot 2021;84(1):169–180; doi: 10.4315/JFP-20-329 [DOI] [PubMed] [Google Scholar]
  • 33. Luna-Pineda VM, Moreno-Fierros L, Cazares-Dominguez V, et al. Curli of uropathogenic Escherichia coli enhance urinary tract colonization as a fitness factor. Front Microbiol 2019;10:2063; doi: 10.3389/fmicb.2019.02063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Biscola FT, Abe CM, Guth BE. Determination of adhesin gene sequences in, and biofilm formation by, O157 and non-O157 Shiga toxin-producing Escherichia coli strains isolated from different sources. Appl Environ Microbiol 2011;77(7):2201–2208; doi: 10.1128/AEM.01920-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Coggon CF, Jiang A, Goh KGK, et al. A novel method of serum resistance by Escherichia coli that causes urosepsis. mBio 2018;9(3):e00920-18; doi: 10.1128/mBio [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Sora VM, Meroni G, Martino PA, et al. Extraintestinal pathogenic Escherichia coli: Virulence factors and antibiotic resistance. Pathogens 2021;10(11):1355; doi: 10.3390/pathogens10111355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Santos ACM, Santos FF, Silva RM, et al. Diversity of hybrid- and hetero-pathogenic Escherichia coli and their potential implication in more severe diseases. Front Cell Infect Microbiol 2020;10:339; doi: 10.3389/fcimb.2020.00339 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Snoeck V, Cox E, Verdonck F, et al. Influence of porcine intestinal pH and gastric digestion on antigenicity of F4 fimbriae for oral immunisation. Vet Microbiol 2004;98(1):45–53; doi: 10.1016/j.vetmic.2003.10.020 [DOI] [PubMed] [Google Scholar]
  • 39. Dewey CE, Straw BE. Herd examination. In: Diseases of Swine. (Straw BE, Zimmerman JJ, D'Alliare S, et al. eds.) Blackwell Publishing: Ames, IA, USA; 2006; pp. 3–14. [Google Scholar]
  • 40. Arraiano CM, Andrade JM, Domingues S, et al. The critical role of RNA processing and degradation in the control of gene expression. FEMS Microbiol Rev 2010;34(5):883–923; doi: 10.1111/j.1574-6976.2010.00242.x [DOI] [PubMed] [Google Scholar]
  • 41. Wang LK, Nandakumar J, Schwer B, et al. The C-terminal domain of T4 RNA ligase 1 confers specificity for tRNA repair. RNA 2007;13(8):1235–1244; doi: 10.1261/rna.591807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Ho CK, Shuman S. Bacteriophage T4 RNA ligase 2 (gp24.1) exemplifies a family of RNA ligases found in all phylogenetic domains. Proc Natl Acad Sci U S A 2002;99(20):12709–12714; doi: 10.1073/pnas.192184699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Dalmasso M, Strain R, Neve H, et al. Three new Escherichia coli phages from the human gut show promising potential for phage therapy. PLoS One 2016;11(6):e0156773; doi: 10.1371/journal.pone.0156773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Guo M, Gao Y, Xue Y, et al. Bacteriophage cocktails protect dairy cows against mastitis caused by drug resistant Escherichia coli infection. Front Cell Infect Microbiol 2021;11:690377; doi: 10.3389/fcimb.2021.690377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Turner D, Kropinski AM, Adriaenssens EM. A roadmap for genome-based phage taxonomy. Viruses 2021;13(3):506; doi: 10.3390/v13030506 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table S1
Supplementary Table S2
Supplementary Table S3
Supplementary Table S4
Supplementary Figure S1
Supplementary Figure S2
Supplementary Figure S3
Supplementary Figure S4
Supplementary Figure S5

Articles from PHAGE: Therapy, Applications, and Research are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES